5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor
Abstract
The present invention relates to a 5-amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative represented by the general formula: wherein R 1 is a hydrogen atom or a lower alkyl group; R 2 represents a hydrogen atom, an optionally substituted lower alkyl group, etc.; R 3 is a di(lower alkyl)amino group, a lower alkyl group, a cycloalkyl group, etc.; Q is a hydrogen atom or an optionally substituted lower alkyl group; and Z is a hydrogen atom or a hydroxy group, etc., or a pharmaceutically acceptable salt thereof, which exerts a potent and selective activated blood coagulation factor X inhibitory activity and is useful as an agent for the prevention or treatment of a disease occurred associating an activated blood coagulation factor X, a pharmaceutical composition comprising the same, a pharmaceutical use thereof and an intermediate thereof.
Claims
exact text as granted — not AI-modified1 - 13 . (canceled)
14 . A 5-cyano-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative represented by the general formula:
wherein
R 1 represents a hydrogen atom or a lower alkyl group;
R 22 represents a hydrogen atom, a lower alkyl group, —Y 1 —COOR A in which Y 1 represents a lower alkylene group or a single bond; and R A represents a hydrogen atom, or a lower alkyl group, —COCOOR B in which R B represents a hydrogen atom or lower alkyl group, —Y 2 —CONH—R C in which Y 2 represents a lower alkylene group or a single bond; and R C represents a hydrogen atom, or a lower alkyl group which may have a substituent selected from the following group (i), —COCONH—R D in which R D is a hydrogen atom or a lower alkyl group which may have a substituent selected from the following group (ii), —CO—Y 3 —R E in which Y 3 is a lower alkylene group or a single bond; and R E represents a 5 to 10-membered aromatic heterocyclic group which may have a lower alkyl group, —CO—Y 41 —R F in which Y 41 is a lower alkylene group which may have one or two optionally protected hydroxy groups; and R F represents —COOR F1 in which R F1 is a hydrogen atom or a lower alkyl group, or a lower alkyl group which may have —COOR G in which R G is a hydrogen atom or a lower alkylsulfonyl group;
(i) —COOR C1 in which R C1 is a hydrogen atom and a lower alkyl group;
(ii) —COOR D1 in which R D1 is a hydrogen atom and a lower alkyl group;
R 3 represents a di(lower alkyl)amino group, a lower alkyl group, a 3 to 10-membered cycloalkyl group, a 6 to 10-membered aryl group which may have one to three substituents selected from the following group (A), a 3 to 10-membered heterocycloalkyl group which may have an oxo group or a 5 to 10-membered aromatic heterocyclic group which may have a substituent selected from the following group (B);
(A) an oxo group, a lower alkyl group, a halo(lower alkyl)group, —Y 5 —R H , a halogen atom, a nitro group, an amino group, —COOR I , a carbamoyl group, a sulfamoyl group, a loweralkylsulfonyl group, a mono(lower alkyl)sulfamoyl group which may have —COOR H , and a loweralkylsulfonylamino-substituted (lower alkyl) group;
wherein Y 5 represents an oxygen atom or a sulfur atom;
R H represents a hydrogen atom, a halo(lower alkyl)group, or a lower alkyl group which may have —COOR H1 in which R H1 is a hydrogen atom, a 3 to 10-membered cycloalkyl group or a lower alkyl group;
R 1 represents a hydrogen atom or a 3 to 10-membered cycloalkyl group or a lower alkyl group;
R J represents a hydrogen atom, a 3 to 10-membered cycloalkyl group or a lower alkyl group;
(B) a lower alkyl group, an amino group and —COOR K ;
wherein R K represents a hydrogen atom, a 3 to 10-membered cycloalkyl group or a lower alkyl group;
Q represents a hydrogen atom or a lower alkyl group which may have a substituent selected from the following group (C);
(C) —OR L , —COOR M , —CONR N R O , a 6 to 10-membered aryl group which may have one to three substituents selected from the following group (iii), and a 5 to 10-membered aromatic heterocyclic group which may have one to three substituents selected from the following group (iv);
wherein R L represents a hydrogen atom or a lower alkyl group which may have —OR L1
where R L1 represents a hydrogen atom or a lower alkyl group;
R M represents a hydrogen atom, a 3 to 10-membered cycloalkyl group, or a lower alkyl group which may have a substituent selected from the following group (v);
R N and R O independently represent a hydrogen atom, a 6 to 10-membered aryl group which may have a carbamoyl group, a 5 to 10-membered aromatic heterocyclic group which may have a substituent selected from the following group (vi), or a lower alkyl group which may have a substituent selected from the following group (vii), or —NR N R O forms a cyclic amino group which may have a substituent selected from the following group (viii);
(v) —COOR M1 in which R M1 is a hydrogen atom, a 3 to 10-membered cycloalkyl group or a lower alkyl group, —OCOR M2 in which R M2 is a 3 to 10-membered cycloalkyl group or a lower alkyl group, —OCOOR M3 in which R M3 is a 3 to 10-membered cycloalkyl group or a lower alkyl group, —OR M4 in which R M4 is a hydrogen atom, a 3 to 10-membered cycloalkyl group or a lower alkyl group, —CONR M5 R M6 in which R M5 and R M6 are independently a hydrogen atom or a lower alkyl group, or —NR M5 R M6 forms a cyclic amino group, a 3 to 10-membered cycloalkyl group, a 6 to 10-membered aryl group, a 3 to 10-membered heterocycloalkyl group, and a 5 to 10-membered aromatic heterocyclic group;
(vi) a halogen atom, a lower alkyl group, a carbamoyl group and —COOR N1 in which R N1 represents a hydrogen atom, or a lower alkyl group;
(vii) —OR N2 in which R N2 is a hydrogen atom or a lower alkyl group, and a 5 to 10-membered aromatic heterocyclic group;
(viii) a hydroxy group, a lower alkyl group, a hydroxy(lower alkyl) group, a carbamoyl group, a di(lower alkyl)amino group, a lower acyl group, and —COOR N3 in which R N3 represents a hydrogen atom or a lower alkyl group;
(iii) a halogen atom, a nitro group, a lower alkyl group, —OR P in which R P is a hydrogen atom or a lower alkyl group, and —COOR Q in which R Q is a hydrogen atom or a lower alkyl group;
(iv) a halogen atom, an oxo group, a lower alkyl group and a phenyl group;
or salt thereof.Join the waitlist — get patent alerts
Track US2006111446A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.